nja-citat--investor-drage-1600x500

WILLIAM DEMANT INVEST A/S

  • Headquartered in Denmark, William Demant Invest is a highly respected evergreen investment company, wholly owned by the charitable William Demant Foundation. William Demant Invest is the majority shareholder in Demant, the leading global hearing healthcare company, Össur, a global leader in non-invasive orthopaedics, as well as Vision RT, a market-leading UK-based medtech company.

  • The investment company also has significant holdings in Vitrolife (assisted reproduction), CellaVision (medical microscopy in the field of hematology), Revenio (ophthalmologic screening and diagnostics), Jeudan (real estate) and Borkum Riffgrund 1 (offshore wind farm). The total number of employees around the world within the William Demant Invest family counts more than 20,000.

  • stable-cash-flow

    Stable and positive cash flow generation

    Read more

  • strong-underlying-market-factors

    Strong underlying market factors

    Read more

  • competent-management

    Competent management

    Read more

  • revenue-around-250m

    Revenue around DKK 250m and strong profitability

    Read more

  • preference-for-listed-companies

    Preference for listed companies

    Read more

  • investments-logos-frontpage-demant

    55-60%

  • investments-logos-frontpage-ossur

    52%

  • investments-logos-frontpage-vision-rt

    89%

  • investments-logos-frontpagevitrolife

    27%

  • investments-logos-frontpage-cellavision

    20%

  • investments-logos-frontpage-revenio

    14%

  • investments-logos-frontpage-invisio

    7%

  • investments-logos-frontpage-jeudan

    42%

  • investments-logos-frontpage-borkum

    19%

  • investments-logos-frontpage-founders

    33%